Articles|  App notes / Features / Science success stories / Interviews / White papers

More and more people who have never smoked tobacco are developing lung cancer. A new genomic analysis revealed that an accumulation of natural mutations led to the disease.

An overgrowth of bacteria in the gut predicted brain injury in preemies.

A new platform enables screening a wide range of combination anticancer therapeutics in a matter of days, which may translate to personalized therapeutic regimens for patients in less time.

A newly developed platform may one day replace cell culture and animal models to personalize cancer treatment.

Heated gold nanoparticles unleash the therapeutic activity of engineered CAR T cells.

Microbiota from young mice reversed some aspects of aging and enhanced brain health in aged mice.

Centenarians have distinct microbiomes with species that produce unique bile acids, which may help thwart illness.

Scientists added a gene circuit that senses and neutralizes proinflammatory ATP to yeast, taking another step towards precision medicine.

Synthetic biologists introduced an engineered microbe that may lead to new treatment options for phenylketonuria.

A device smaller than two stacked decks of cards can reliably detect and discriminate between SARS-CoV-2 variants in spit in less than an hour with results that glow.

Researchers are taking the concept of three-dimensional cell culture beyond single organoids to develop embryos from cells.

An unusual drug screen takes advantage of “porcupine-like” structures of cancer cells in 3D organoids.

Pradipta Ghosh has plans to revolutionize the drug discovery pipeline.

An unfolded protein found in human milk shows promise in early clinical trials to treat bladder cancer.

A clever approach to modifying already existing cancer therapies may be a game changer for treating metastatic breast cancer.

Guidelines and built-in safeguards ensure the reproducibility of flow cytometry data.

Single-cell analysis provides a superior view of heterogeneous cell populations.

An unexpected and unprecedented finding may lead to improved cancer therapies.

Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.

Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.